Follow
  • Privacy Policy
  • US News
  • Europe
  • Asia
  • Africa
  • Latin America and the Caribbean
  • Canada
  • Indian subcontinent
  • Australia
  • Middle East
Outbreak News Today
BREAKING
  • Chikungunya: Philippines reports more than 1400 cases to date, a 213% increase
  • Philippines: Leptospirosis cases up 70 percent in 2023, Nearly nine out of 10 cases in males
  • Aeromonas skin infections outbreak linked to Tough Mudder adventure race at Sonoma Raceway
  • Vietnam: Diphtheria outbreak reported in Dien Bien province
  • Dengue in Florida: 4 additional local cases reported in Miami-Dade County
  • Outbreak News Radio
  • Interviews
  • Drugs and antibiotics
  • Vaccines
  • Research
  • Blogs
TRENDING
  • US News
  • Latin America and the Caribbean
  • Animal diseases
Home » Headlines » Universal influenza vaccine: An NIAID priority

Universal influenza vaccine: An NIAID priority

by Press Release
February 28, 2018
Headlines, Vaccines
1 Comment

Developing a universal influenza vaccine — a vaccine that can provide durable protection for all age groups against multiple influenza strains, including those that might cause a pandemic — is a priority for the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Writing in the Journal of Infectious Diseases, NIAID officials detail the Institute’s new strategic plan for addressing the research areas essential to creating a safe and effective universal influenza vaccine. They describe the scientific goals that will be supported to advance influenza vaccine development. The strategic plan builds upon a workshop NIAID convened in June 2017 that gathered scientists from academia, industry and government who developed criteria for defining a universal influenza vaccine, identified knowledge gaps, and delineated research strategies for addressing those gaps.

 Influenza A virions Image/CDC
Influenza A virions
Image/CDC

Flu Vaccine Act introduced by Sen. Edward Markey: For the creation of a universal influenza vaccine

The cornerstone of both seasonal and pandemic influenza prevention and control is the development of vaccines against specific influenza strains that pose a potentially significant risk to the public. Seasonal influenza vaccines are made anew each year to best match the strains projected to circulate in the upcoming season. However, this approach has limitations and difficulties. To reduce the public health consequences of both seasonal and pandemic influenza, vaccines must be more broadly and durably protective. Advances in influenza virology, immunology and vaccinology make the development of a universal influenza vaccine more feasible than a decade ago, according to the authors. To develop a universal influenza vaccine, NIAID will focus resources on three key areas of influenza research: improving the understanding of the transmission, natural history and pathogenesis of influenza infection; precisely characterizing how protective influenza immunity occurs and how to tailor vaccination responses to achieve it; and supporting the rational design of universal influenza vaccines, including designing new immunogens and adjuvants to boost immunity and extend the duration of protection.

The authors state that a coordinated effort of guided discovery, facilitated product development and managed progress through iterative clinical testing will be critical to achieving the goal of a universal influenza vaccine. NIAID will establish and support a consortium of scientists to meet designated goals for a universal influenza vaccine and will expand the Institute’s research resources by establishing long-term human cohorts, supporting improved animal models of influenza infection and expanding capacity for conducting human challenge studies.

The authors emphasize that broad collaboration and coordination in many disciplines and involving government, academia, philanthropies and the private sector will be vital to achieving the goal of developing a universal influenza vaccine. NIAID intends for the plan to serve as the foundation for its research investment strategy to achieve this important public health goal.

 

One thought on “Universal influenza vaccine: An NIAID priority”

  1. Pingback: Universal Flu Vaccine: Senators ask NIAID for update | The Global Dispatch | The Global Dispatch

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Walk-In Lab STD Testing

Newsletter

Subscribe to our periodic Newsletter

* indicates required
  • Popular
  • Comments
  • Tags

FDA warning: Ivermectin meant for animals are not for human treatment for COVID-19

Ivermectin is highly effective as a safe prophylaxis and treatment for COVID-19: Comprehensive review

Lyme discovery: Borrelia bacteria hides inside parasitic worms, causing chronic brain diseases

A Look at Human Botfly Infestation

Johns Hopkins researchers: Plant compounds may be better than current antibiotics at treating persistent Lyme bacteria

ticks

Lyme disease and other tickborne diseases in the US

How contagious is measles? Answer: Very

ALS research and treatments update in Orlando

CDC Warns About Thomson International Onions in Salmonella Outbreak

Pinworms: They only come out at night

Africa anthrax Australia bird flu Brazil California Canada chikungunya China cholera coronavirus COVID-19 dengue dengue fever Ebola Europe Florida food recall hepatitis A Hong Kong India influenza Legionnaire's disease Lyme disease malaria measles monkeypox mumps New York Nigeria norovirus outbreak Pakistan parasites Philippines plague polio rabies salmonella syphilis Texas vaccines Vietnam West Nile virus Zika virus

About Us

Outbreak News Today
Outbreak News Today is an online blog magazine which focuses on news and information about infectious diseases and outbreaks. Editor-In-Chief: Robert Herriman Contact: [email protected]
blood shirt

Recent Posts

  • Chikungunya: Philippines reports more than 1400 cases to date, a 213% increase
  • Philippines: Leptospirosis cases up 70 percent in 2023, Nearly nine out of 10 cases in males
  • Aeromonas skin infections outbreak linked to Tough Mudder adventure race at Sonoma Raceway
  • Vietnam: Diphtheria outbreak reported in Dien Bien province
  • Dengue in Florida: 4 additional local cases reported in Miami-Dade County
  • Canada: 3 residents part of botulism outbreak in France
  • Nipah virus in Kerala update: ‘There hasn’t been a second wave’
  • Italy locally transmitted dengue cases rise to 19
  • California: Shigella outbreak investigated, Likely linked to Los Angeles hotel
  • Texas reports additional animal anthrax cases in 2023
  • South Dakota report 1st anthrax cases of 2023 in a Ziebach county beef herd
  • Arkansas: Naegleria fowleri death reported, Linked to a Little Rock splash pad
  • Sweden reports significant rise in tularemia in 2023
  • Norway: E. coli outbreak linked to hamburgers, 15 cases reported
  • The infectious disease situation in Ethiopia
  • Paraguay reports 9 confirmed hantavirus cases, 3 deaths in 2023 to date
  • Argentina reports decline in dengue
  • Nigeria: Confirmed Lassa fever cases reported from Ondo and Edo states in latest update
  • NIH: Universal Flu Vaccine, FluMos-v2, designed to target 6 flu strains begins clinical trials
  • Illinois: Salmonella outbreak linked to Chicago establishment sickens 20
© Copyright Outbreak News Today
Cleantalk Pixel

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Outbreak News Today
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.